Literature DB >> 29593331

GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability.

Wang Lai Hu1,2,3, Lei Jin4, An Xu1, Yu Fang Wang5, Rick F Thorne2,6, Xu Dong Zhang7,8, Mian Wu9,10.   

Abstract

The list of long non-coding RNAs (lncRNAs) involved in the p53 pathway of the DNA damage response is rapidly expanding, but whether lncRNAs have a role in maintaining the de novo structure of DNA is unknown. Here, we demonstrate that the p53-responsive lncRNA GUARDIN is important for maintaining genomic integrity under steady-state conditions and after exposure to exogenous genotoxic stress. GUARDIN is necessary for preventing chromosome end-to-end fusion through maintaining the expression of telomeric repeat-binding factor 2 (TRF2) by sequestering microRNA-23a. Moreover, GUARDIN also sustains breast cancer 1 (BRCA1) stability by acting as an RNA scaffold to facilitate the heterodimerization of BRCA1 and BRCA1-associated RING domain protein 1 (BARD1). As such, GUARDIN silencing triggered apoptosis and senescence, enhanced cytotoxicity of additional genotoxic stress and inhibited cancer xenograft growth. Thus, GUARDIN may constitute a target for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29593331     DOI: 10.1038/s41556-018-0066-7

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  108 in total

Review 1.  lncRedibly versatile: biochemical and biological functions of long noncoding RNAs.

Authors:  Emily J Shields; Ana F Petracovici; Roberto Bonasio
Journal:  Biochem J       Date:  2019-04-10       Impact factor: 3.857

2.  Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.

Authors:  Ling Zhang; Jin Zhang; Shujing Li; Yanyan Zhang; Yun Liu; Jian Dong; Wenjun Zhao; Bo Yu; Huifang Wang; Jing Liu
Journal:  RNA Biol       Date:  2020-09-20       Impact factor: 4.652

Review 3.  Noncoding RNAs Controlling Telomere Homeostasis in Senescence and Aging.

Authors:  Martina Rossi; Myriam Gorospe
Journal:  Trends Mol Med       Date:  2020-02-28       Impact factor: 11.951

4.  BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites.

Authors:  Zhaohua Hu; Shaojie Mi; Ting Zhao; Changmin Peng; Yihan Peng; Lulu Chen; Wenge Zhu; Yi Yao; Qibin Song; Xiangpan Li; Xinzhi Li; Chenxi Jia; Huadong Pei
Journal:  EMBO J       Date:  2020-04-29       Impact factor: 11.598

5.  Emerging roles of long non-coding RNAs in the p53 network.

Authors:  Abhinav K Jain
Journal:  RNA Biol       Date:  2020-06-04       Impact factor: 4.652

6.  S-phase Enriched Non-coding RNAs Regulate Gene Expression and Cell Cycle Progression.

Authors:  Ozlem Yildirim; Enver C Izgu; Manashree Damle; Vladislava Chalei; Fei Ji; Ruslan I Sadreyev; Jack W Szostak; Robert E Kingston
Journal:  Cell Rep       Date:  2020-05-12       Impact factor: 9.423

7.  Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-β/Smad signaling pathway in lung cancer.

Authors:  Lele Xu; Wenzhong Liu; Tongtong Li; Yuying Hu; Yu Wang; Lijie Huang; Yan Wang; Shujuan Shao; Xuefeng Liu; Qimin Zhan
Journal:  Oncogene       Date:  2021-04-30       Impact factor: 9.867

8.  SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.

Authors:  Elizabeth V Minten; Priya Kapoor-Vazirani; Chunyang Li; Hui Zhang; Kamakshi Balakrishnan; David S Yu
Journal:  Cell Rep       Date:  2021-03-30       Impact factor: 9.423

9.  LncRNA GUARDIN suppresses cellular senescence through a LRP130-PGC1α-FOXO4-p21-dependent signaling axis.

Authors:  Xuedan Sun; Rick Francis Thorne; Xu Dong Zhang; Miao He; Jinming Li; Shanshan Feng; Xiaoying Liu; Mian Wu
Journal:  EMBO Rep       Date:  2020-03-09       Impact factor: 8.807

10.  SNHG1 represses the anti-cancer roles of baicalein in cervical cancer through regulating miR-3127-5p/FZD4/Wnt/β-catenin signaling.

Authors:  Xiaolan Yu; Jiyi Xia; Yong Cao; Li Tang; Xiaoping Tang; Zhengyu Li
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.